Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | +8.27% |
|
-2.37% | -62.35% |
Jun. 27 | GT Biopharma Says FDA Clears Investigational New Drug Application for Cancer Drug GTB-3650 | MT |
Jun. 27 | GT Biopharma Shares Rise on FDA Clearance for Cancer-Drug Study | DJ |
Official Publications
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
1st quarter results | CO | |
Proxy Statments | CO | |
SEC Filing 8K | CO | |
SEC Filing 10K | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
3rd quarter results | CO | |
SEC Filing 10Q-3 | CO | |
SEC Filing 8K | CO | |
1st-half-year results | CO | |
SEC Filing 10Q-2 | CO | |
SEC Filing 8K | CO | |
Shareholders meeting voting results | CO | |
1st quarter results | CO | |
SEC Filing 10Q-1 | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
Annual results | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- GTBP Stock
- News GT Biopharma, Inc.
- Official Publications